Ubisoft narrows Avatar, Skull & Bones and Mario + Rabbids 2 release windows
They’ll arrive in the second half of the company’s current fiscal year
Ubisoft has provided an update on its product release slate, including several premium titles.
In its full-year earnings report published on Wednesday, the company said Avatar: Frontiers of Pandora, Mario + Rabbids: Sparks of Hope and Skull & Bones are on track to release during its current fiscal year ending on March 31, 2023.
Speaking on the company’s earnings call, chief corporate finance officer Frédérick Duguet narrowed the release windows for the three games to the second half of the fiscal year, meaning they won’t be released before October 1, 2022.
Avatar: Frontiers of Pandora and Mario + Rabbids: Sparks of Hope were both previously confirmed for release in calendar year 2022, so they should arrive in the last three months of the year. Skull & Bones could release in this window too, or during the first three months of 2023.
James Cameron’s Avatar: The Way of Water is currently scheduled to hit cinemas on December 16, 2022.
“Avatar: Frontiers of Pandora is coming on [the back of] the movie that we expect will be one of the biggest movies of the year, probably of the next few years, so we are confident that it’s going to be a big title,” Ubisoft CEO Yves Guillemot said during the company’s earnings call (transcribed by VGC).
“On Skull & Bones, we have been working quite hard on that product so we plan to really bring something fresh to the market”.
Ubisoft put out a call for Skull & Bones testers in March and according to the game’s website, a release date is “coming soon”.
A six-minute Skull & Bones video leaked in April, providing an overview of what players can expect from Ubisoft Singapore’s long-delayed pirate adventure.
During today’s earnings call, Guillemot also commented on speculation that Ubisoft could be the subject of a takeover bid. He said the company “has everything we need to remain independent” but reiterated that the board would consider any offers in the interest of shareholders.